NEWS

What we are up to:

Visit TECHLAB® at ASM Microbe 2018

TECHLAB® is proud to be an exhibitor at ASM Microbe 2018.  Visit us in Booth #2031.   Poster Presentations:   Evaluation of Biological and Immunological Stability of Clostridium difficile Glutamate Dehydrogenase and Toxin at Different Storage Conditions in Stool Specimens Friday, June 8th (11 am -1 pm) #340   Improved Detection of Campylobacter in Human … Continue reading

May 16, 2018

Webinar: Clostridium difficile Infection Guideline Update: Understanding the Data Behind the Recommendations

C. difficile infections pose a serious threat and require rapid clinical decisions. In this webinar, Dr. Dubberke will review the 2017 IDSA/SHEA CDI guideline update treatment recommendations, describe how the 2017 IDSA/SHEA CDI guideline update recommendations on C. difficile diagnostics will apply to a patient population, and identify how the microbiology laboratory can assist in … Continue reading

March 23, 2018

Webinar: Fecal Lactoferrin Measurements in Clinical Practice

Many of the symptoms of inflammatory bowel disease overlap (IBD)with those of irritable bowel syndrome (IBS).  Elevated lactoferrin is an indicator of intestinal inflammation. Fecal lactoferrin testing is a non-invasive metric that can be used to help differentiate IBD and IBS patients presenting with non-specific gastrointestinal symptoms.  In this webinar, Paul Rufo,  MD, MSSc will … Continue reading

March 23, 2018

PRESS RELEASE: Techlab Products Identified as Meeting Updated Clinical Practice Guidelines for Clostridium difficile Infection

BLACKSBURG, Va., Feb. 26, 2018 /PRNewswire/ — TECHLAB, Inc., today announced its products meet the updated Clinical Practice Guidelines for Clostridium difficile from The Infectious Disease Society of America (IDSA) and the Society of Healthcare Epidemiology of America (SHEA). The new recommendations recently published in the journal Clinical Infectious Diseases, emphasize the value of immunoassay … Continue reading

February 26, 2018

2018 IDSA/SHEA C. difficile Guideline Authors Stress the Importance of Multistep Algorithm Testing

Mark H. Wilcox, MD, FRCPath, a consultant and the head of microbiology research and development at Leeds Teaching Hospitals NHS Trust, in England, said the United Kingdom also has changed its protocols for testing. “We have changed the recommendation for CDI laboratory diagnosis to highlight that the best-performing method (i.e., positive and negative predictive value) … Continue reading

February 26, 2018

PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance to Market CAMPYLOBACTER QUIK CHEK and CAMPYLOBACTER CHEK Tests

  BLACKSBURG, Va. – January 23, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the CAMPYLOBACTER QUIK CHEK™ and the CAMPYLOBACTER CHEK™ tests. Both are intended to aid diagnosis of campylobacteriosis, one of the most common … Continue reading

January 23, 2018

PRESS RELEASE: Phoenix Lab to Offer GIARDIA VET CHEK From TECHLAB®

BLACKSBURG, Va. and MUKILTEO, Wash. – January 11, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the … Continue reading

January 11, 2018

PRESS RELEASE: Advanced Veterinary Laboratory to Offer GIARDIA VET CHEK From TECHLAB®

BLACKSBURG, Va. – January 3, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it will supply Advanced Veterinary Laboratory (AVL) with the GIARDIA VET CHEK™ test, the first USDA licensed Giardia microwell ELISA available for use in dogs and cats. The GIARDIA VET CHEK™ test offers … Continue reading

January 3, 2018

PRESS RELEASE: TECHLAB® Receives USDA Establishment License and Product License for GIARDIA VET CHEK™

BLACKSBURG, Va. – November 8, 2017 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the first … Continue reading

November 17, 2017

PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance To Market TRI-COMBO PARASITE SCREEN™ To Aid Clinicians In The Diagnosis Of Giardiasis, Cryptosporidiosis, And Amebiasis

Read the full release here. BLACKSBURG, Va., July 13, 2017 /PRNewswire/ — TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the TRI-COMBO PARASITE SCREEN™ test. The TRI-COMBO PARASITE SCREEN ™ test provides a complete analysis for Giardia, Cryptosporidium, and Entamoeba histolytica, the three most common intestinal protozoan … Continue reading

July 13, 2017
  • 1
  • 2